DVA - DaVita HealthCare Partners EPS beats by $0.10 beats on revenue narrows guidance range
DaVita HealthCare Partners (NYSE:DVA): Q3 Non-GAAP EPS of $2.36 beats by $0.10; GAAP EPS of $2.36 beats by $0.17. Revenue of $2.94B (+0.7% Y/Y) beats by $30M. 2021 Guidance: Adjusted EPS to range between $8.80-$9.15, compared to prior guidance of 8.80-$9.40 vs. consensus of $9.18 Press Release
For further details see:
DaVita HealthCare Partners EPS beats by $0.10, beats on revenue, narrows guidance range